134 related articles for article (PubMed ID: 15958564)
1. Tumor-associated NH2-terminal fragments are the most stable part of the adenomatous polyposis coli protein and can be regulated by interactions with COOH-terminal domains.
Li Z; Näthke IS
Cancer Res; 2005 Jun; 65(12):5195-204. PubMed ID: 15958564
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the role of the adenomatous polyposis coli protein in colon cancer and its contribution to cytoskeletal regulation.
Näthke I
Biochem Soc Trans; 2005 Aug; 33(Pt 4):694-7. PubMed ID: 16042576
[TBL] [Abstract][Full Text] [Related]
3. The adenomatous polyposis coli protein (APC) exists in two distinct soluble complexes with different functions.
Penman GA; Leung L; Näthke IS
J Cell Sci; 2005 Oct; 118(Pt 20):4741-50. PubMed ID: 16188939
[TBL] [Abstract][Full Text] [Related]
4. Adenomatous polyposis coli (APC) protein regulates epithelial cell migration and morphogenesis via PDZ domain-based interactions with plasma membranes.
Mimori-Kiyosue Y; Matsui C; Sasaki H; Tsukita S
Genes Cells; 2007 Feb; 12(2):219-33. PubMed ID: 17295841
[TBL] [Abstract][Full Text] [Related]
5. Nup358 interacts with APC and plays a role in cell polarization.
Murawala P; Tripathi MM; Vyas P; Salunke A; Joseph J
J Cell Sci; 2009 Sep; 122(Pt 17):3113-22. PubMed ID: 19654215
[TBL] [Abstract][Full Text] [Related]
6. Non-traditional roles for the Adenomatous Polyposis Coli (APC) tumor suppressor protein.
Hanson CA; Miller JR
Gene; 2005 Nov; 361():1-12. PubMed ID: 16185824
[TBL] [Abstract][Full Text] [Related]
7. Truncating APC mutations have dominant effects on proliferation, spindle checkpoint control, survival and chromosome stability.
Tighe A; Johnson VL; Taylor SS
J Cell Sci; 2004 Dec; 117(Pt 26):6339-53. PubMed ID: 15561772
[TBL] [Abstract][Full Text] [Related]
8. Association and regulation of casein kinase 2 activity by adenomatous polyposis coli protein.
Homma MK; Li D; Krebs EG; Yuasa Y; Homma Y
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5959-64. PubMed ID: 11972058
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of the adenomatous polyposis coli protein and its possible regulatory effects in cells.
Bhattacharya G; Boman BM
Biochem Biophys Res Commun; 1995 Mar; 208(1):103-10. PubMed ID: 7887918
[TBL] [Abstract][Full Text] [Related]
10. Functional definition of the mutation cluster region of adenomatous polyposis coli in colorectal tumours.
Kohler EM; Derungs A; Daum G; Behrens J; Schneikert J
Hum Mol Genet; 2008 Jul; 17(13):1978-87. PubMed ID: 18387968
[TBL] [Abstract][Full Text] [Related]
11. Examination of actin and microtubule dependent APC localisations in living mammalian cells.
Langford KJ; Askham JM; Lee T; Adams M; Morrison EE
BMC Cell Biol; 2006 Jan; 7():3. PubMed ID: 16423286
[TBL] [Abstract][Full Text] [Related]
12. N-terminal truncation mutations of adenomatous polyposis coli are associated with primary cilia defects.
Song L; Jia Y; Zhu W; Newton IP; Li Z; Li W
Int J Biochem Cell Biol; 2014 Oct; 55():79-86. PubMed ID: 25150829
[TBL] [Abstract][Full Text] [Related]
13. The APC protein binds to A/T rich DNA sequences.
Deka J; Herter P; Sprenger-Haussels M; Koosch S; Franz D; Müller KM; Kuhnen C; Hoffmann I; Müller O
Oncogene; 1999 Oct; 18(41):5654-61. PubMed ID: 10523845
[TBL] [Abstract][Full Text] [Related]
14. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours.
Kohler EM; Chandra SH; Behrens J; Schneikert J
Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359
[TBL] [Abstract][Full Text] [Related]
15. Regulation and function of the interaction between the APC tumour suppressor protein and EB1.
Askham JM; Moncur P; Markham AF; Morrison EE
Oncogene; 2000 Apr; 19(15):1950-8. PubMed ID: 10773885
[TBL] [Abstract][Full Text] [Related]
16. Dynamic properties of APC-decorated microtubules in living cells.
Dayanandan R; Butler R; Gordon-Weeks PR; Matus A; Kaech S; Lovestone S; Anderton BH; Gallo JM
Cell Motil Cytoskeleton; 2003 Mar; 54(3):237-47. PubMed ID: 12589682
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations.
Segditsas S; Sieber OM; Rowan A; Setien F; Neale K; Phillips RK; Ward R; Esteller M; Tomlinson IP
Exp Mol Pathol; 2008 Dec; 85(3):201-6. PubMed ID: 18977219
[TBL] [Abstract][Full Text] [Related]
18. Truncation mutations abolish chromatin-associated activities of adenomatous polyposis coli.
Kouzmenko AP; Takeyama K; Kawasaki Y; Akiyama T; Kato S
Oncogene; 2008 Aug; 27(36):4888-99. PubMed ID: 18454178
[TBL] [Abstract][Full Text] [Related]
19. Ligand-dependent interaction between estrogen receptor alpha and adenomatous polyposis coli.
Kouzmenko AP; Takeyama K; Kawasaki Y; Akiyama T; Kato S
Genes Cells; 2008 Jul; 13(7):723-30. PubMed ID: 18498351
[TBL] [Abstract][Full Text] [Related]
20. Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression.
Song Y; Zhang C
Cancer Chemother Pharmacol; 2009 Mar; 63(4):605-13. PubMed ID: 18521605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
